Review
doi: 10.1007/978-1-4684-3258-9_9.
Newer hypolipidemic compounds
- PMID: 1106139
- DOI: 10.1007/978-1-4684-3258-9_9
Item in Clipboard
Review
Newer hypolipidemic compounds
Adv Exp Med Biol.
1975.
No abstract available
Similar articles
-
One-year trials with halofenate, clofibrate, and placebo.Clin Pharmacol Ther. 1976 Mar;19(3):352-9. doi: 10.1002/cpt1976193352. Clin Pharmacol Ther. 1976. PMID: 177242 Clinical Trial.
-
The metabolic spectrum of halofenate.Int J Clin Pharmacol Biopharm. 1975 Jul;12(1-2):239-43. Int J Clin Pharmacol Biopharm. 1975. PMID: 51838 Clinical Trial.
-
Comparison of the effects of halofenate (MK-185) and clofibrate on plasma lipid and uric acid concentration in hyperlipoproteinemic patients.Atherosclerosis. 1975 May-Jun;21(3):391-9. doi: 10.1016/0021-9150(75)90051-9. Atherosclerosis. 1975. PMID: 1148032 Clinical Trial.
-
Methods and endpoint issues in clinical development of lipid-acting agents with pleiotropic effects.Am J Cardiol. 1998 Apr 23;81(8A):17F-24F. doi: 10.1016/s0002-9149(98)00253-7. Am J Cardiol. 1998. PMID: 9604899 Review. No abstract available.
-
[Probucol].Nihon Rinsho. 2001 Mar;59 Suppl 3:631-6. Nihon Rinsho. 2001. PMID: 11347145 Review. Japanese. No abstract available.
Cited by
-
Hypolipidemic drugs are inhibitors of phosphatidylcholine synthesis.Proc Natl Acad Sci U S A. 1982 Nov;79(22):6890-3. doi: 10.1073/pnas.79.22.6890. Proc Natl Acad Sci U S A. 1982. PMID: 6294663 Free PMC article.